Current stock page

Stock Analysis

Neogen Corporation (NEOG) Stock Analysis

Neogen Corporation (NEOG) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.

NEOG Stock Analysis Summary

Neogen Corporation (NEOG) currently has an AIQ Score of 63/100, indicating a neutral setup. Momentum is the strongest factor at 74/100. Value is the weakest current factor at 49/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 18, 2026 · Market-close data

NEOG at a Glance

Crawlable current metrics from the latest market-close stock snapshot.

MetricCurrent
Price$11.08
AIQ Score63/100
Overall ViewNeutral
Technical Analysis ConsensusStrong Sell
Market Cap$2.45B
P/E Ratio (TTM)-43.05
Forward P/E—
EPS (Q1 FY2027)-$0.05
Revenue (Q1 FY2027)$222.8M
Dividend Yield (TTM)0.00%
Beta1.41
Volume1.79M
52-week range$5.37-$14.26
RSI 1440.09
50-Day SMA$12.24
200-Day SMA$10.51
Analyst Price Target$14.00
Next EarningsJan 14, 2027
As of Nov 18, 2026 · Market close

NEOGNeogen Corporation

Healthcare / Medical - Devices

Low Priority

Above Peers

NeutralEdge 7/10
$11.08+$0.18 (+1.65%)

Latest quote

  • Momentum
    74
  • Value
    49
  • Quality
    63
  • Risk resilience
    57
  • Sentiment
    —
algovestiq.comScore data as of Nov 18, 2026

NEOG Stock Analysis Summary

Neogen Corporation (NEOG) currently has an AIQ Score of 63/100, indicating a neutral setup. Momentum is the strongest factor at 74/100. Value is the weakest current factor at 49/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 18, 2026 · Market-close data
AIQ Composite Posture: Neutral

In a neutral regime, NEOG has AIQ Score of 63/100 with Momentum base of 74/100 and fading Value at 49/100. Wait for component alignment before adding exposure.

Signal Conflict Detected

Momentum (74/100) leads while Value (49/100) lags. This cross-factor spread creates entry timing uncertainty.

Healthcare · 1.65% stock move · NEOG classified in Medical - Devices.

Current Evidence

NeutralNEOG is in a neutral AIQ regime; Momentum is the strongest visible factor at 74/100.
Core coverage reflects visible evidence only

AlgovestIQ Evidence Summary

Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.

Is NEOG Bullish or Bearish Right Now?

NEOG currently has a neutral overall setup. Momentum is the strongest factor at 74/100, while Value is weakest at 49/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.

Bull Case
  • - Momentum is constructive at 74/100.
  • - Analyst target implies +26.35% upside from the latest quote.
Bear Case
  • - Value is the current constraint at 49/100.
  • - Technical consensus has more sell votes than buy votes (34 vs 8).

Current Consensus

NEOG's Technical Analysis Consensus is currently Strong Sell, with 8 buy, 4 neutral, and 34 sell votes. NEOG's 14-day RSI is 40.09, which places the stock in a weaker momentum range. NEOG's beta is 1.41, indicating greater market sensitivity than the broad market.

Signal Confidence
High agreement

What Changed in NEOG?

The largest recent change in NEOG is Momentum moving down by 4.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.

AIQ Score
-1.0
Momentum
-4.0
Quality
+0.0
Risk
+1.0

What Would Change the NEOG Outlook?

The current neutral outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.

Bullish confirmation

AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.

Bearish deterioration

AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.

NEOG Decision Framework

Public evidence layers, setup checks, and risk context for Neogen Corporation.

Neogen Corporation (NEOG) Stock Analysis

Neogen Corporation has an AIQ Score of 63/100 in a Neutral regime. Momentum is strongest at 74/100. Beta is 1.41, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.

Evidence LayerPublic Evidence
Regime ContextNEOG is in a Neutral AIQ regime with score 63/100.
Signal ConflictThe primary conflict is that momentum leads at 74/100 while value lags at 49/100.
Factor EvidenceMomentum 74/100 · Value 49/100 · Quality 63/100 · Risk 57/100
PersistenceCurrent snapshot evidence is shown; historical persistence remains in AIQ Pro.

Current Setup Checklist

Factor strengthPass

Momentum is the strongest factor at 74/100.

TimingPass

Momentum is 74/100 and RSI (14) is 40.1.

Regime fitWait

NEOG is in a Neutral regime at 63/100.

Risk controlWait

Risk factor is 57/100 with beta 1.41 and annual volatility 57.93%.

ConflictWait

Current conflict: momentum leads at 74/100 while value lags at 49/100.

AIQ Score
63/100
Price
$11.08
Beta
1.41
RSI (14)
40.1

NEOG Research Cluster

Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.

NEOG Fundamentals

NEOG valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.

Revenue
$222.8M
Net income
-$11.9M
Free cash flow
$4.7M
View full NEOG fundamental analysis

NEOG Technical Analysis

NEOG technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.

Technical Analysis Consensus
Strong Sell
RSI 14
40.09
Price vs SMA-50
-8.24%
View full NEOG technical analysis

NEOG Stock Catalysts

Track NEOG earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.

Next earnings
Jan 14, 2027
Analyst target
$14.00
News items
5
View NEOG earnings and stock catalysts

NEOG Dividend Analysis

NEOG dividend yield, annual dividend, payout ratio, payment history, and income reliability context.

Dividend yield
0.00%
Annual dividend
—
Payout ratio
—
View NEOG dividend history and analysis

NEOG Financial Data

NEOG revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.

Quarter revenue
$222.8M
EPS
-$0.05
Periods
8
View NEOG financials

NEOG Risk Analysis

NEOG volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.

Beta
1.41
Risk score
57/100
1Y volatility
57.93%
View NEOG risk analysis

NEOG Stock News

NEOG stock news, market tone, recent headlines, and catalyst context.

News items
5
Updated
Nov 18, 2026
Sentiment
—
Read NEOG stock news

NEOG vs Medical - Devices Peers

Current peer cohort: NEOG · PACB · PEN · PHG · PRCT. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.

PeerAIQValueMomentumRiskSharpe1Y VolatilityCompare
NEOG
Current stock
63/10049/10074/10057/1001.1957.93%Current
PACB
Pacific Biosciences of California, Inc.
48/10023/10084/10024/1000.6193.55%NEOG vs PACB
PEN
Penumbra, Inc.
66/10048/10056/10092/1000.6219.46%NEOG vs PEN
PHG
Koninklijke Philips N.V.
72/10080/10072/10073/1000.1829.69%NEOG vs PHG
PRCT
PROCEPT BioRobotics Corporation
49/10038/10060/10045/100-0.1165.89%NEOG vs PRCT
Pairwise Compare links: PACB · PEN · PHG · PRCTNEOG vs PACBNEOG vs PENNEOG vs PHGNEOG vs PRCTCompare cohort

Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 18, 2026.

About the AIQ Score

Methodology for the current stock evidence.

As of Nov 18, 2026 · Market close

The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.

View AIQ methodology

Factor Diagnostics

A compact bridge from the AIQ score to the evidence tabs.

Calculator
Calculate a NEOG stock return scenario

Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.

Calculate stock return

Also for NEOG: historical return with reinvested dividends, dollar-cost averaging (DCA) backtest and stock average calculator for several buys.

AIQ Component Profile

Compare the five component scores on one consistent 0–100 scale.

Catalyst preview

Review earnings timing, revisions, news pressure, and prior event reactions in one place.

Open catalysts
Quarterly evidence

8 recent quarterly periods are available for review.

Checked Nov 19, 2026

AIQ Pro

Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.

Fundamentals Verdict

Current snapshot fields are separate from reported-quarter statement tables.

Current TTM P/E
-43.05
As of Nov 18, 2026
Revenue growth
6.51%
Gross margin
47.40%
Current debt / equity
0.37
Latest quarterly evidence

Latest period Aug 31, 2026.

Review fundamentals
Quarter revenue
$222.8M
Quarter net income
-$11.9M
Quarter free cash flow
$4.7M

Market Confirmation

Technicals are summarized first, with the indicator library behind it.

Trend
Mixed
Momentum
Bearish
RSI 14
40.09
MACD
-0.19

Risk Alignment

Higher resilience is stronger; exposure metrics stay separate.

Resilience
57/100
Beta
1.41
Annual volatility
57.93%
Max drawdown
-27.71%

NEOG Stock FAQ

What is NEOG stock price today?

Neogen Corporation's current stock price is $11.08. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.

Is NEOG bullish or bearish right now?

NEOG's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.

What is NEOG's market cap?

NEOG's market cap is $2.45B based on the latest completed market-close snapshot from Nov 18, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.

What is NEOG's current P/E ratio?

NEOG's current P/E ratio is -43.05 based on the latest completed market-close snapshot from Nov 18, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.

What is NEOG's RSI?

NEOG's 14-day RSI is 40.09 based on the latest completed market-close snapshot from Nov 18, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.

Is NEOG above its 50-day and 200-day moving averages?

NEOG is -8.24% from its 50-day SMA and 6.80% from its 200-day SMA based on the latest completed market-close snapshot from Nov 18, 2026. Moving-average position should be read with momentum and broader AIQ evidence.

When is NEOG's next earnings date?

NEOG's next earnings date is currently listed as Jan 14, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.

Does NEOG pay a dividend?

NEOG's dividend yield is 0.00% based on the latest completed market-close snapshot from Nov 18, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.